Efflux of taurocholic acid across the blood-brain barrier: Interaction with cyclic peptides

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 890-895

  Kitazawa, Takeo ^b   Terasaki, Tetsuya ^a,b   Suzuki, Hiroshi ^b   Kakee, Atsuyuki ^b   Sugiyama, Yuichi ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; CHOLIC ACID; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOPEPTIDE; INULIN; OCTREOTIDE; PROBENECID; TAUROCHOLIC ACID; VAPREOTIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ELIMINATION; DRUG PENETRATION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TIGHT JUNCTION; TRANSPORT KINETICS;

ANIMALS; BLOOD-BRAIN BARRIER; CHOLAGOGUES AND CHOLERETICS; CHOLIC ACID; CHOLIC ACIDS; HORMONES; LIGANDS; MALE; MICROINJECTIONS; OCTREOTIDE; PEPTIDES, CYCLIC; PERFUSION; RATS; RATS, WISTAR; TAUROCHOLIC ACID; TIME FACTORS;

EID: 0032437785     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Angeletti RH, Novikoff PM, Juvvadi SR, Fritschy JM, Meier PJ and Wolkoff AW (1997) The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc Natl Acad Aci USA 94:283-286.
2. Banks WA and Kastin AJ (1990) Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol 259:E1-E10.
3. Banks WA, Kastin AJ, Sam HM, Cao VT, King B, Maness LM and Schally AV (1989) Saturable efflux of the peptides RC-160 and Tyr-MIF-1 by different parts of the blood-brain barrier. Brain Res Bull 35:179-182.
4. Büchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T and Keppler D (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMRP, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271:15091-15098.
5. Cornford EM, Diep CP and Pardridge WM (1985) Blood-brain barrier transport of valproic acid. J Neurochem 44:1541-1550.
6. Deguchi Y, Nozawa K, Yamada S, Yokoyama Y and Kimura R (1997) Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: Possible involvement of the monocarboxylic acid transport system. J Pharmacol Exp Ther 280:551-560.
7. Dykstra KH, Arya A, Arriola DM, Bungay PM, Morrison PF and Dedrik RL (1993) Microdialysis study of Zidovudine (AZT) transport in rat brain. J Pharmacol Exp Ther 267:1227-1236.
8. Friedman LS, Martin P and Munoz SJ (1996) Liver function tests and the objective evaluation of the patient with liver disease, in Hepatology: A Textbook of Liver Disease, 3rd ed (Zakin D and Boyer TD eds) pp 791-833, WB Saunders, Philadelphia.
9. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1997) Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 272:G16-G22.
10. Kakee A, Terasaki T and Sugiyama Y (1996) Brain efflux index as a nobel method of analyzing efflux transport at the blood-brain barrier. J Pharmacol Exp Ther 277:1550-1559.
11. Kakee A, Terasaki T and Sugiyama Y (1997) Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: In vivo evidence using the brain efflux index (BEI) method. J Pharmacol Exp Ther 283:1018-1025.
12. Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M and Sugiyama Y (1997) P-glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther 283:574-580.
13. Kusuhara H, Suzuki H, Naito M, Tsuruo T and Sugiyama Y (1998) Efflux of organic anions from a mouse brain capillary endothelial cell line (MBEC4) is mediated by MRP. J Pharmacol Exp Ther 285:1260-1265.
14. Leininger B, Ghersi-egea JF, Siest G and Minn A (1991) In vivo study of the elimination from rat brain of an intracerebrally formed xenobiotic metabolite, 1-naphthyl-β-D-glucuronide. J Neurochem 56:1163-1168.
15. Levin VA (1980) Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23:682-684.
16. Meier PJ (1995) Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol 269:G801-G812.
17. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B and Stieger B (1997) Substrate specificity of sinusoidal bile acid and organic anon uptake systems in rat and human liver. Hepatology 26:1667-1677.
18. Nakamura T, Hisaka A, Sawasaki Y, Suzuki Y, Fukami T, Ishikawa K, Yano M and Sugiyama Y (1996) Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes. J Pharmacol Exp Ther 278:564-572.
19. Ooie T, Terasaki T, Suzuki H and Sugiyama Y (1997) Kinetic evidence for active transport at the blood-brain barrier of quinolone antibiotics. J Pharmacol Exp Ther 283:293-304.
20. Pardridge WM (1991) Peptide Derug Delivery to the Brain. Raven, New York.
21. Pardridge WM, Triguero D, Yang J and Cancilla PA (1990) Comparison of in vitro and in vivo modeles of drug transcytosis through the blood-brain barrier. J Pharmacol Exp Ther 253:884-891.
22. Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P and Oude Elferink RPJ (1996) Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Sci 271:1126-1128.
23. Roda A, Minutello A, Angellotti MA and Fini A (1990) Bile acid structure - activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC. J Lipid Res 31:1433-1443.
24. Schinkel AH, Mayer U, Wagennar E, Mol CAAM, van Deemter L, Smit JJM, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JMJM, Fibbe WE and Borst P (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033.
25. Seeff LB (1996) Liver function tests and the objective evaluation of the patient with liver disease, in Hepatology: A Textbook of Liver Disease, 3rd ed. (Zakim D and Boyer TD, eds) W.B. Saunders Company, Philadelphia, PA.
26. Shin H-C, Kato Y, Yamada T, Ninuma K, Hisaka A and Sugiyama Y (1997) Hepatobiliary transport mechanism for the cyclopentapeptide endothelin antagonist BQ-123. Am J Physiol 272:G979-G986.
27. Steen H, Merema M and Meijer DKF (1992) A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liver. Biochem Pharmacol 44:2323-2331.
28. Suzuki H, Terasaki T and Sugiyama Y (1997) Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system. Adv Drug Deliv Rev 25:257-285.
29. Takasato Y, Rapoport SI and Smith QR (1984) An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 247:H484-H493.
30. Takasawa T, Terasaki T, Suzuki H, Ooie T and Sugiyama Y (1997a) In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J Pharmacol Exp Ther 281:369-375.
31. Takasawa T, Terasaki T, Suzuki H, Ooie T and Sugiyama Y (1997b) Distributed model analysis of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine distribution in brain tissue and cerebrospinal fluid. J Pharmacol Exp Ther 282:1508-1517.
32. Terasaki T, Mizuguchi H, Itoho C, Tamai I, Lemaire M and Tsuji A (1995) Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system. Pharm Res 12:12-17.
33. Tsuji A and Tamai I (1997) Blood-brain barrier function of P-glycoprotein. Adv Drug Deliv Rev 25:287-298.
34. Yamada T, Niinuma K, Lemaire M, Terasaki T and Sugiyama Y (1996) Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide. J Pharmacol Exp Ther 279:1357-1364.
35. Yamada T, Niinuma K, Lemaire M, Terasaki T and Sugiyama Y (1997) Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats: Comparison between in vivo and in vitro. Drug Metab Dispos 25:536-543.
36. Yamazaki M, Suzuki H and Sugiyama Y (1996) Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res 13:497-513.
37. Ziegler K, Kolac C and Ising W (1994) ATP-dependent transport of the linear renin-inhibiting peptide EMD-51921 by canalicular plasma membrane vesicles of rat liver: Evidence of drug-stimulatable ATP-hydrolysis. Biochim Biophys Acta 1196:209-217.
38. Zlokovic BV (1995) Cerebrovascular permeability to peptides: Manipulations of transport systems at the blood-brain barrier. Pharm Res 12:1395-1406.